Mouse models for studies of HLA-G functions in basic science and pre-clinical research

被引:8
|
作者
Anh Thu Nguyen-Lefebvre [1 ]
Ajith, Ashwin [1 ]
Portik-Dobos, Vera [1 ]
Horuzsko, Daniel D. [1 ]
Mulloy, Laura L. [2 ]
Horuzsko, Anatolij [1 ,2 ]
机构
[1] Georgia Regents Univ, Ctr Canc, Mol Oncol & Biomarkers Program, 1140 Laney Walker Blvd, Augusta, GA 30912 USA
[2] Georgia Regents Univ, Dept Med, 1120 15th St, Augusta, GA 30912 USA
关键词
HLA-G; Transgenic mice; Humanized mice; Transplantation; MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I MOLECULES; CHORIOCARCINOMA CELL-LINE; DENDRITIC CELLS; HUMANIZED MICE; INHIBITORY RECEPTOR; TRANSGENIC MICE; MYELOMONOCYTIC CELLS; BIOMEDICAL-RESEARCH; T-LYMPHOCYTES;
D O I
10.1016/j.humimm.2016.02.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HLA-G was described originally as a tolerogenic molecule that allows the semiallogeneic fetus to escape from recognition by the maternal immune response. This review will discuss different steps in the study of HLA-G expression and functions in vivo, starting with analyses of expression of the HLA-G gene and its receptors in transgenic mice, and continuing with applications of HLA-G and its receptors in prevention of allograft rejection, transplantation tolerance, and controlling the development of infection. Humanized mouse models have been discussed for developing in vivo studies of HLA-G in physiological and pathological conditions. Collectively, animal models provide an opportunity to evaluate the importance of the interaction between HLA-G and its receptors in terms of its ability to regulate immune responses during maternal-fetal tolerance, survival of allografts, tumor escape mechanisms, and development of infections when both HLA-G and its receptors are expressed. In addition, in vivo studies on HLA-G also offer novel approaches to achieve a reproducible transplantation tolerance and to develop personalized medicine to prevent allograft rejection. (C) 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:711 / 719
页数:9
相关论文
共 50 条
  • [21] The Role of Biological Sex in Pre-Clinical (Mouse) mRNA Vaccine Studies
    Binici, Burcu
    Rattray, Zahra
    Schroeder, Avi
    Perrie, Yvonne
    VACCINES, 2024, 12 (03)
  • [22] Compelling Reasons to Perform Basic and Pre-clinical Research on Germline Genome Editing
    Aquino-Jarquin, Guillermo
    STEM CELL REVIEWS AND REPORTS, 2023, 19 (07) : 2554 - 2555
  • [23] Compelling Reasons to Perform Basic and Pre-clinical Research on Germline Genome Editing
    Guillermo Aquino-Jarquin
    Stem Cell Reviews and Reports, 2023, 19 : 2554 - 2555
  • [24] Development of molecular therapies for Duchenne muscular dystrophy: basic and pre-clinical studies
    van Ommen, GB
    NEUROMUSCULAR DISORDERS, 2002, 12 (7-8) : 783 - 783
  • [25] Sex as a Critical Variable in Basic and Pre-Clinical Studies of Fibrodysplasia Ossificans Progressiva
    Burdick, Lorraine N.
    DelVichio, Amanda H.
    Hanson, L. Russell
    Griffith, Brenden B.
    Bouchard, Keith R.
    Hunter, Jeffrey W.
    Goldhamer, David J.
    BIOMOLECULES, 2024, 14 (02)
  • [26] Gene Therapeutic Strategies for Congenital Anosmias: Translating Basic Science and Pre-clinical Work
    Martens, Jeffrey R.
    CHEMICAL SENSES, 2016, 41 (07) : E6 - E6
  • [27] Enhancing pre-clinical research with simplified intestinal cell line models
    Fey, Christina
    Truschel, Theresa
    Nehlsen, Kristina
    Damigos, Spyridon
    Horstmann, Julia
    Stradal, Theresia
    May, Tobias
    Metzger, Marco
    Zdzieblo, Daniela
    JOURNAL OF TISSUE ENGINEERING, 2024, 15
  • [28] Mouse models of myeloproliferative neoplasms for pre-clinical testing of novel therapeutic agents
    Stetka, Jan
    Skoda, Radek C.
    BIOMEDICAL PAPERS-OLOMOUC, 2021, 165 (01): : 26 - 33
  • [29] Pre-Clinical Mouse Models of SCLC to Identify and Validate New Therapeutic Targets
    Lim, Jing
    Jahchan, Nadine
    Yang, Dian
    George, Julie
    Peifer, Martin
    Thomas, Roman K.
    Sage, Julien
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S99 - S99
  • [30] Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies
    Tsermpini, Evangelia Eirini
    Redensek, Sara
    Dolzan, Vita
    FRONTIERS IN PHARMACOLOGY, 2022, 12